B. Kuenburg

Development of a Pilot Scale Process for the Anti-Alzheimer Drug (−)-Galanthamine Using Large-Scale Phenolic Oxidative Coupling and Crystallisation-Induced Chiral Conversion

B. Kuenburg, L. Czollner, Johannes Fröhlich et al. · Organic Process Research & Development · 1999 · 117 citations

Bioorganic Chemistry, Pharmaceutical Chemistry, Medicinal Chemistry +16

New kilogram-synthesis of the anti-alzheimer drug (−)-galanthamine

L. Czollner, Werner Frantsits, B. Kuenburg et al. · Tetrahedron Letters · 1998 · 67 citations

Medicinal Chemistry, New Kilogram-synthesis, Medicine +5

Synthesis of (1<i>R</i>,4<i>R</i>)- and (1<i>S</i>,4<i>S</i>)-2,5-Diazabicyclo[2.2.1]heptanes and Their<i>N</i>-Substituted Derivatives

Ulrich Jordis, F. Sauter, Suhaib M. Siddiqi et al. · Synthesis · 1990 · 40 citations

Bioorganic Chemistry, Derivatives, Biochemistry +12

Enantiomeric resolution of galanthamine and related drugs used in anti-Alzheimer therapy by means of capillary zone electrophoresis employing derivatized cyclodextrin selectors

Andreas Rizzi, R. Schuh, Andrea Brückner et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1999 · 30 citations

Cyclodextrin Selectors, Biochemistry, Medicine +9